https://marchcp.com/wp-content/uploads/2021/11/Screen-Shot-2021-11-18-at-10.37.11-AM.png9101220March Capitalhttps://marchcp.com/wp-content/uploads/2020/11/MC__Logo.pngMarch Capital2021-11-18 10:45:402021-12-30 08:58:53Generate Biomedicines raises $370M Series B with a focus on protein-based drugs
Expel – Simplifying Security: a $15B+ Opportunity
Scroll to top